These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

413 related items for PubMed ID: 22488006

  • 1. Heparin or 0.9% sodium chloride to maintain central venous catheter patency: a randomized trial.
    Schallom ME, Prentice D, Sona C, Micek ST, Skrupky LP.
    Crit Care Med; 2012 Jun; 40(6):1820-6. PubMed ID: 22488006
    [Abstract] [Full Text] [Related]

  • 2. Keeping central venous lines open: a prospective comparison of heparin, vitamin C and sodium chloride sealing solutions in medical patients.
    Rabe C, Gramann T, Sons X, Berna M, González-Carmona MA, Klehr HU, Sauerbruch T, Caselmann WH.
    Intensive Care Med; 2002 Aug; 28(8):1172-6. PubMed ID: 12185445
    [Abstract] [Full Text] [Related]

  • 3. Comparison of Oligon catheters and chlorhexidine-impregnated sponges with standard multilumen central venous catheters for prevention of associated colonization and infections in intensive care unit patients: a multicenter, randomized, controlled study.
    Arvaniti K, Lathyris D, Clouva-Molyvdas P, Haidich AB, Mouloudi E, Synnefaki E, Koulourida V, Georgopoulos D, Gerogianni N, Nakos G, Matamis D, Catheter-Related Infections in ICU (CRI-ICU) Group.
    Crit Care Med; 2012 Feb; 40(2):420-9. PubMed ID: 21926583
    [Abstract] [Full Text] [Related]

  • 4. National survey of central venous catheter flushing in the intensive care unit.
    Sona C, Prentice D, Schallom L.
    Crit Care Nurse; 2012 Feb; 32(1):e12-9. PubMed ID: 22298726
    [Abstract] [Full Text] [Related]

  • 5. The efficacy of heparinization in prolonging patency of arterial and central venous catheters in children: a randomized double-blind trial.
    de Neef M, Heijboer H, van Woensel JB, de Haan RJ.
    Pediatr Hematol Oncol; 2002 Dec; 19(8):553-60. PubMed ID: 12487830
    [Abstract] [Full Text] [Related]

  • 6. Evaluation of the effects of heparinized and nonheparinized flush solutions on the patency of arterial pressure monitoring lines: the AACN Thunder Project. By the American Association of Critical-Care Nurses.
    Am J Crit Care; 1993 Jan; 2(1):3-15. PubMed ID: 8353575
    [Abstract] [Full Text] [Related]

  • 7. A randomized, controlled trial of heparin versus placebo infusion to prolong the usability of peripherally placed percutaneous central venous catheters (PCVCs) in neonates: the HIP (Heparin Infusion for PCVC) study.
    Shah PS, Kalyn A, Satodia P, Dunn MS, Parvez B, Daneman A, Salem S, Glanc P, Ohlsson A, Shah V.
    Pediatrics; 2007 Jan; 119(1):e284-91. PubMed ID: 17200252
    [Abstract] [Full Text] [Related]

  • 8. Heparin sodium versus 0.9% sodium chloride injection for maintaining patency of indwelling intermittent infusion devices.
    Hamilton RA, Plis JM, Clay C, Sylvan L.
    Clin Pharm; 1988 Jun; 7(6):439-43. PubMed ID: 3402178
    [Abstract] [Full Text] [Related]

  • 9. Heparinized saline versus normal saline in maintaining patency of the radial artery catheter.
    Kulkarni M, Elsner C, Ouellet D, Zeldin R.
    Can J Surg; 1994 Feb; 37(1):37-42. PubMed ID: 8306218
    [Abstract] [Full Text] [Related]

  • 10. Sodium citrate versus heparin catheter locks for cuffed central venous catheters: a single-center randomized controlled trial.
    Power A, Duncan N, Singh SK, Brown W, Dalby E, Edwards C, Lynch K, Prout V, Cairns T, Griffith M, McLean A, Palmer A, Taube D.
    Am J Kidney Dis; 2009 Jun; 53(6):1034-41. PubMed ID: 19394731
    [Abstract] [Full Text] [Related]

  • 11. Efficacy of 0.9% sodium chloride injection with and without heparin for maintaining indwelling intermittent injection sites.
    Epperson EL.
    Clin Pharm; 1984 Jun; 3(6):626-9. PubMed ID: 6509875
    [Abstract] [Full Text] [Related]

  • 12. The effects of heparin flush on patency of the Groshong catheter: a pilot study.
    Mayo DJ, Horne MK, Summers BL, Pearson DC, Helsabeck CB.
    Oncol Nurs Forum; 1996 Oct; 23(9):1401-5. PubMed ID: 8899756
    [Abstract] [Full Text] [Related]

  • 13. Comparison of normal saline and heparin solutions for maintenance of arterial catheter patency.
    Clifton GD, Branson P, Kelly HJ, Dotson LR, Record KE, Phillips BA, Thompson JR.
    Heart Lung; 1991 Mar; 20(2):115-8. PubMed ID: 2004920
    [Abstract] [Full Text] [Related]

  • 14. A vancomycin-heparin lock solution for prevention of nosocomial bloodstream infection in critically ill neonates with peripherally inserted central venous catheters: a prospective, randomized trial.
    Garland JS, Alex CP, Henrickson KJ, McAuliffe TL, Maki DG.
    Pediatrics; 2005 Aug; 116(2):e198-205. PubMed ID: 15995005
    [Abstract] [Full Text] [Related]

  • 15. A randomized trial comparing gentamicin/citrate and heparin locks for central venous catheters in maintenance hemodialysis patients.
    Moran J, Sun S, Khababa I, Pedan A, Doss S, Schiller B.
    Am J Kidney Dis; 2012 Jan; 59(1):102-7. PubMed ID: 22088576
    [Abstract] [Full Text] [Related]

  • 16. Comparison of silver-impregnated with standard multi-lumen central venous catheters in critically ill patients.
    Kalfon P, de Vaumas C, Samba D, Boulet E, Lefrant JY, Eyraud D, Lherm T, Santoli F, Naija W, Riou B.
    Crit Care Med; 2007 Apr; 35(4):1032-9. PubMed ID: 17334256
    [Abstract] [Full Text] [Related]

  • 17. A prospective, randomized trial of rifampicin-minocycline-coated and silver-platinum-carbon-impregnated central venous catheters.
    Fraenkel D, Rickard C, Thomas P, Faoagali J, George N, Ware R.
    Crit Care Med; 2006 Mar; 34(3):668-75. PubMed ID: 16505651
    [Abstract] [Full Text] [Related]

  • 18. A novel antimicrobial and antithrombotic lock solution for hemodialysis catheters: a multi-center, controlled, randomized trial.
    Maki DG, Ash SR, Winger RK, Lavin P, AZEPTIC Trial Investigators.
    Crit Care Med; 2011 Apr; 39(4):613-20. PubMed ID: 21200319
    [Abstract] [Full Text] [Related]

  • 19. Prospective, randomized trial of two different modalities of flushing central venous catheters in pediatric patients with cancer.
    Cesaro S, Tridello G, Cavaliere M, Magagna L, Gavin P, Cusinato R, Zadra N, Franco Zanon G, Zanesco L, Carli M.
    J Clin Oncol; 2009 Apr 20; 27(12):2059-65. PubMed ID: 19273702
    [Abstract] [Full Text] [Related]

  • 20. Heparin versus 0.9% sodium chloride intermittent flushing for prevention of occlusion in central venous catheters in adults.
    López-Briz E, Ruiz Garcia V, Cabello JB, Bort-Marti S, Carbonell Sanchis R, Burls A.
    Cochrane Database Syst Rev; 2014 Oct 08; (10):CD008462. PubMed ID: 25300172
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.